Literature DB >> 25741860

Legislation in the genomic era: the Affordable Care Act and genetic testing for cancer risk assessment.

Farzana L Walcott1,2, Barbara K Dunn1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25741860     DOI： 10.1038/gim.2015.18

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  4 in total

1.  Concise handbook of familial cancer susceptibility syndromes - second edition.

Authors:  Noralane M Lindor; Mary L McMaster; Carl J Lindor; Mark H Greene
Journal:  J Natl Cancer Inst Monogr       Date:  2008

2.  Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.

Authors:  Amy P M Finch; Jan Lubinski; Pål Møller; Christian F Singer; Beth Karlan; Leigha Senter; Barry Rosen; Lovise Maehle; Parviz Ghadirian; Cezary Cybulski; Tomasz Huzarski; Andrea Eisen; William D Foulkes; Charmaine Kim-Sing; Peter Ainsworth; Nadine Tung; Henry T Lynch; Susan Neuhausen; Kelly A Metcalfe; Islay Thompson; Joan Murphy; Ping Sun; Steven A Narod
Journal:  J Clin Oncol       Date:  2014-02-24       Impact factor: 44.544

Review 3.  BRCA mutation testing in determining breast cancer therapy.

Authors:  Karen Lisa Smith; Claudine Isaacs
Journal:  Cancer J       Date:  2011 Nov-Dec       Impact factor: 3.360

4.  The Affordable Care Act and genetic testing for inheritable cancer syndromes: impact on high-risk underserved minorities.

Authors:  Farzana L Walcott; Barbara K Dunn; Mary DeShields; Claudia Baquet
Journal:  J Health Care Poor Underserved       Date:  2014-02
  4 in total
  6 in total

1.  Cancer Survivorship Care: An Opportunity to Revisit Cancer Genetics.

Authors:  Kathryn J Ruddy; Betsy C Risendal; Judy E Garber; Ann H Partridge
Journal:  J Clin Oncol       Date:  2015-12-28       Impact factor: 44.544

2.  Validation of an Efficient Screening Tool to Identify Low-Income Women at High Risk for Hereditary Breast Cancer.

Authors:  Susan L Stewart; Celia P Kaplan; Robin Lee; Galen Joseph; Leah Karliner; Jennifer Livaudais-Toman; Rena J Pasick
Journal:  Public Health Genomics       Date:  2016-10-28       Impact factor: 2.000

3.  Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancer.

Authors:  Carlos H Barcenas; Maryam N Shafaee; Arup K Sinha; Akshara Raghavendra; Babita Saigal; Rashmi K Murthy; Ashley H Woodson; Banu Arun
Journal:  J Natl Compr Canc Netw       Date:  2018-05       Impact factor: 11.908

4.  Review of applications of high-throughput sequencing in personalized medicine: barriers and facilitators of future progress in research and clinical application.

Authors:  Gaye Lightbody; Valeriia Haberland; Fiona Browne; Laura Taggart; Huiru Zheng; Eileen Parkes; Jaine K Blayney
Journal:  Brief Bioinform       Date:  2019-09-27       Impact factor: 11.622

5.  Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO).

Authors:  Yusuke Kobayashi; Kenta Masuda; Akira Hiraswa; Kazuhiro Takehara; Hitoshi Tsuda; Yoh Watanabe; Katsutoshi Oda; Satoru Nagase; Masaki Mandai; Aikou Okamoto; Nobuo Yaegashi; Mikio Mikami; Takayuki Enomoto; Daisuke Aoki; Hidetaka Katabuchi
Journal:  J Gynecol Oncol       Date:  2022-07-18       Impact factor: 4.756

6.  Integrating fundamental cause theory and Bourdieu to explain pathways between socioeconomic status and health: the case of health insurance denials for genetic testing.

Authors:  Emily Hammad Mrig
Journal:  Sociol Health Illn       Date:  2020-10-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.